Company news
Arterra Bioscience Spa (MIL:ARBS) news
Arterra Bioscience Spa news releases on 6ix. Latest, May 6, 2026: ARBS: Quarterly revenue up 22.21% to €1.6M, led by strong cosmetic raw material sales
Press releases & updates
ARBS: Quarterly revenue up 22.21% to €1.6M, led by strong cosmetic raw material sales
May 6, 2026
Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
April 21, 2026
ARBS: Strong profit growth and innovation in cosmetic biotech drive improved margins and outlook
March 27, 2026
Arterra Bioscience FY Revenue At EUR 4.6 Mln
February 10, 2026
Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital
January 20, 2026
Arterra Bioscience 9M Revenue EUR 3.6 Mln
November 6, 2025
ARBS: H1 2025 saw 35.5% revenue growth, 143% EBITDA increase, and robust net profit margin
September 29, 2025
ARBS: Revenue up 12.8% year-over-year to €2.6M, led by strong cosmetic raw material sales growth
July 18, 2025
ARBS: Q1 2025 revenue rose 21.6% year-over-year to €1.3 million, led by cosmetic raw material sales
May 6, 2025
ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal
March 28, 2025
ARBS: Revenue up 28.21% to €4.2M, driven by strong cosmetic raw materials sales growth
February 13, 2025
ARBS: Revenue up 7% year-over-year to €2.8 million, with strong growth in cosmetic raw materials
November 4, 2024
ARBS: Strong H1 2024 growth in revenue and profit, with optimism for continued expansion
September 26, 2024
ARBS: Revenue up 43% in 1H 2024, led by strong cosmetic raw material sales growth
July 18, 2024